细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2747人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979258, encodeId=5a2a19e9258bd, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：新开发的改良ALBI分级显示更好的肝细胞癌预后和预测价值, objectType=article, longId=264974, objectId=fc8b2649e44f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc8b2649e44f, replyNumber=0, likeNumber=82, createdTime=2022-09-18, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc8b2649e44f, moduleTitle=Liver Cancer：新开发的改良ALBI分级显示更好的肝细胞癌预后和预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc8b2649e44f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979330, encodeId=9fac19e9330b9, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：MEDI0680+Durvalumab vs 纳武单抗治疗晚期肾透明细胞癌, objectType=article, longId=726302, objectId=68e5e26302bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e5e26302bd, replyNumber=0, likeNumber=85, createdTime=2022-12-22, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e5e26302bd, moduleTitle=Clin Cancer Res：MEDI0680+Durvalumab vs 纳武单抗治疗晚期肾透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68e5e26302bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979276, encodeId=16b319e927657, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, objectType=article, longId=294112, objectId=1b49294112ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b49294112ae, replyNumber=0, likeNumber=91, createdTime=2022-05-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b49294112ae, moduleTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b49294112ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979338, encodeId=5efe19e93383d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=CGH: HBeAg阳性不会对慢性乙型肝炎患者口服抗病毒治疗期间肝细胞癌风险产生影响, objectType=article, longId=728103, objectId=4b08e2810361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b08e2810361, replyNumber=0, likeNumber=82, createdTime=2022-11-02, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b08e2810361, moduleTitle=CGH: HBeAg阳性不会对慢性乙型肝炎患者口服抗病毒治疗期间肝细胞癌风险产生影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b08e2810361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979260, encodeId=0c3919e9260fc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Cancer：真实世界研究比较二线afatinib (阿法替尼)对比化疗治疗一线化疗后进展的晚期肺鳞状细胞癌患者的疗效, objectType=article, longId=291850, objectId=7bef291850d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bef291850d8, replyNumber=0, likeNumber=74, createdTime=2022-05-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bef291850d8, moduleTitle=BMC Cancer：真实世界研究比较二线afatinib (阿法替尼)对比化疗治疗一线化疗后进展的晚期肺鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bef291850d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979237, encodeId=b61219e923774, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, objectType=article, longId=220495, objectId=dbd22204957c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd22204957c, replyNumber=0, likeNumber=59, createdTime=2022-04-16, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd22204957c, moduleTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbd22204957c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979262, encodeId=ab8d19e9262ca, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=AP&T: 慢性病毒性肝炎并发脂肪肝的肝细胞癌风险和死亡率会明显增加, objectType=article, longId=292156, objectId=66a129215625, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66a129215625, replyNumber=0, likeNumber=66, createdTime=2022-01-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66a129215625, moduleTitle=AP&T: 慢性病毒性肝炎并发脂肪肝的肝细胞癌风险和死亡率会明显增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66a129215625)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979345, encodeId=65fa19e9345ca, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ADV：Sonidegib治疗局部晚期基底细胞癌回顾性研究, objectType=article, longId=728083, objectId=7358e280834f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7358e280834f, replyNumber=0, likeNumber=68, createdTime=2023-05-11, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7358e280834f, moduleTitle=ADV：Sonidegib治疗局部晚期基底细胞癌回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7358e280834f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979259, encodeId=4e4219e92591e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：立体定向放疗（SBRT）联合免疫治疗（SBRT-IO）对比TACE治疗局部进展期肝细胞癌患者的疗效, objectType=article, longId=264987, objectId=306f26498e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=306f26498e26, replyNumber=0, likeNumber=97, createdTime=2022-10-15, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=306f26498e26, moduleTitle=Front Oncol：立体定向放疗（SBRT）联合免疫治疗（SBRT-IO）对比TACE治疗局部进展期肝细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=306f26498e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979307, encodeId=df1519e93078a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：ATTRACTION-3研究3年随访生存结果表明nivolumab较化疗改善晚期食管鳞状细胞癌（ESCC）患者预后, objectType=article, longId=301417, objectId=e1c330141efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1c330141efe, replyNumber=0, likeNumber=68, createdTime=2022-09-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1c330141efe, moduleTitle=Clin Cancer Res：ATTRACTION-3研究3年随访生存结果表明nivolumab较化疗改善晚期食管鳞状细胞癌（ESCC）患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1c330141efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979270, encodeId=60f619e9270fc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：随机对照研究证实小肝细胞癌患者使用手术和射频消融治疗无显著差异, objectType=article, longId=293506, objectId=e33529350618, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e33529350618, replyNumber=0, likeNumber=76, createdTime=2022-07-30, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e33529350618, moduleTitle=Liver Cancer：随机对照研究证实小肝细胞癌患者使用手术和射频消融治疗无显著差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e33529350618)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979374, encodeId=37e419e9374bb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Braz J Otorhinolaryngol：头颈部皮肤鳞状细胞癌和基底细胞癌的细胞动力学标志物, objectType=article, longId=738416, objectId=a32de3841614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a32de3841614, replyNumber=0, likeNumber=98, createdTime=2023-03-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a32de3841614, moduleTitle=Braz J Otorhinolaryngol：头颈部皮肤鳞状细胞癌和基底细胞癌的细胞动力学标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a32de3841614)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979315, encodeId=472e19e931584, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Dermatol：老年人的基底细胞癌：如何决定何时进行积极监测或警惕等待, objectType=article, longId=302222, objectId=7402302222e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7402302222e2, replyNumber=0, likeNumber=86, createdTime=2022-07-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7402302222e2, moduleTitle=Br J Dermatol：老年人的基底细胞癌：如何决定何时进行积极监测或警惕等待, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7402302222e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979355, encodeId=8d1f19e935515, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatology Communications：这几种饮食习惯与肝细胞癌息息相关！, objectType=article, longId=733260, objectId=6aa1e3326091, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aa1e3326091, replyNumber=0, likeNumber=117, createdTime=2022-12-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aa1e3326091, moduleTitle=Hepatology Communications：这几种饮食习惯与肝细胞癌息息相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aa1e3326091)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979245, encodeId=9d6419e92458e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=肝内胆管细胞癌诊疗现状研究, objectType=article, longId=221127, objectId=543422112e8a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=543422112e8a, replyNumber=0, likeNumber=39, createdTime=2022-05-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=543422112e8a, moduleTitle=肝内胆管细胞癌诊疗现状研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=543422112e8a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979218, encodeId=3d2f19e921822, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=The Oncologist：PPIs的联合使用对Cabozantinib（卡博替尼）治疗转移性肾细胞癌(mRCC)的影响, objectType=article, longId=219184, objectId=9df12191846b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9df12191846b, replyNumber=0, likeNumber=66, createdTime=2022-03-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9df12191846b, moduleTitle=The Oncologist：PPIs的联合使用对Cabozantinib（卡博替尼）治疗转移性肾细胞癌(mRCC)的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9df12191846b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979375, encodeId=021819e93758e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAMA Oncol：Telaglenstat联合卡博替尼治疗转移性晚期肾细胞癌, objectType=article, longId=738547, objectId=dd49e385472d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd49e385472d, replyNumber=0, likeNumber=75, createdTime=2023-04-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd49e385472d, moduleTitle=JAMA Oncol：Telaglenstat联合卡博替尼治疗转移性晚期肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd49e385472d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979333, encodeId=230d19e9333cd, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, objectType=article, longId=727477, objectId=0a19e27477f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a19e27477f4, replyNumber=0, likeNumber=63, createdTime=2022-07-26, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a19e27477f4, moduleTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a19e27477f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979351, encodeId=9e1d19e935105, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAMA Netw open：转移性肾细胞癌患者“免疫-肿瘤联合治疗”后的影像学反应, objectType=article, longId=730177, objectId=5ba9e3017707, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ba9e3017707, replyNumber=0, likeNumber=90, createdTime=2023-01-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ba9e3017707, moduleTitle=JAMA Netw open：转移性肾细胞癌患者“免疫-肿瘤联合治疗”后的影像学反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ba9e3017707)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979206, encodeId=80f719e920667, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：FOLFOX方案肝动脉灌注化疗(HAIC)联合索拉非尼较单用HAIC改善晚期肝细胞癌的预后, objectType=article, longId=217919, objectId=fd5021e9197a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd5021e9197a, replyNumber=0, likeNumber=71, createdTime=2022-03-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd5021e9197a, moduleTitle=Front Oncol：FOLFOX方案肝动脉灌注化疗(HAIC)联合索拉非尼较单用HAIC改善晚期肝细胞癌的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd5021e9197a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：新开发的改良ALBI分级显示更好的肝细胞癌预后和预测价值

2022-09-18

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：MEDI0680+Durvalumab vs 纳武单抗治疗晚期肾透明细胞癌

2022-12-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效

2022-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

CGH: HBeAg阳性不会对慢性乙型肝炎患者口服抗病毒治疗期间肝细胞癌风险产生影响

2022-11-02

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Cancer：真实世界研究比较二线afatinib (阿法替尼)对比化疗治疗一线化疗后进展的晚期肺鳞状细胞癌患者的疗效

2022-05-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性

2022-04-16

qingting (审核中...)

前往app查看评论内容

#细胞癌#

AP&T: 慢性病毒性肝炎并发脂肪肝的肝细胞癌风险和死亡率会明显增加

2022-01-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ADV：Sonidegib治疗局部晚期基底细胞癌回顾性研究

2023-05-11

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：立体定向放疗（SBRT）联合免疫治疗（SBRT-IO）对比TACE治疗局部进展期肝细胞癌患者的疗效

2022-10-15

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：ATTRACTION-3研究3年随访生存结果表明nivolumab较化疗改善晚期食管鳞状细胞癌（ESCC）患者预后

2022-09-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：随机对照研究证实小肝细胞癌患者使用手术和射频消融治疗无显著差异

2022-07-30

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Braz J Otorhinolaryngol：头颈部皮肤鳞状细胞癌和基底细胞癌的细胞动力学标志物

2023-03-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Dermatol：老年人的基底细胞癌：如何决定何时进行积极监测或警惕等待

2022-07-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatology Communications：这几种饮食习惯与肝细胞癌息息相关！

2022-12-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

肝内胆管细胞癌诊疗现状研究

2022-05-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

The Oncologist：PPIs的联合使用对Cabozantinib（卡博替尼）治疗转移性肾细胞癌(mRCC)的影响

2022-03-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAMA Oncol：Telaglenstat联合卡博替尼治疗转移性晚期肾细胞癌

2023-04-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS

2022-07-26

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAMA Netw open：转移性肾细胞癌患者“免疫-肿瘤联合治疗”后的影像学反应

2023-01-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：FOLFOX方案肝动脉灌注化疗(HAIC)联合索拉非尼较单用HAIC改善晚期肝细胞癌的预后

2022-03-25

科室
- - 订阅+
  - 更多科室
工具
服务